- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7373
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Rethinking medulloblastoma from a targeted therapeutics perspective ; day:5 ; month:6 ; year:2018 ; pages:1-8
Journal of neuro-oncology ; (5.6.2018), 1-8
- Creator
-
Hashimoto, Yuuri
- Contributor
-
Penas-Prado, Marta
Zhou, Shouhao
Wei, Jun
Khatua, Soumen
Hodges, Tiffany R.
Sanai, Nader
Xiu, Joanne
Gatalica, Zoran
Kim, Lyndon
Kesari, Santosh
Rao, Ganesh
Spetzler, David
Heimberger, Amy
SpringerLink (Online service)
- DOI
-
10.1007/s11060-018-2917-2
- URN
-
urn:nbn:de:101:1-2018081119483811366660
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hashimoto, Yuuri
- Penas-Prado, Marta
- Zhou, Shouhao
- Wei, Jun
- Khatua, Soumen
- Hodges, Tiffany R.
- Sanai, Nader
- Xiu, Joanne
- Gatalica, Zoran
- Kim, Lyndon
- Kesari, Santosh
- Rao, Ganesh
- Spetzler, David
- Heimberger, Amy
- SpringerLink (Online service)
Other Objects (12)
Melanoma : Biologically Targeted Therapeutics
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Plasmonic Material Engineering for Targeted Therapeutics
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Rethinking Photography: A Historical Perspective
Oligonucleotide therapeutics in sports? An antidoping perspective
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Progress and challenges towards targeted delivery of cancer therapeutics
Medulloblastoma cerebelli
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Melanoma : Biologically Targeted Therapeutics
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Plasmonic Material Engineering for Targeted Therapeutics
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Rethinking Photography: A Historical Perspective
Oligonucleotide therapeutics in sports? An antidoping perspective
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Progress and challenges towards targeted delivery of cancer therapeutics
Medulloblastoma cerebelli
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Melanoma : Biologically Targeted Therapeutics
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Plasmonic Material Engineering for Targeted Therapeutics
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Rethinking Photography: A Historical Perspective
Oligonucleotide therapeutics in sports? An antidoping perspective
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Progress and challenges towards targeted delivery of cancer therapeutics
Medulloblastoma cerebelli